艾尔建 (Chinese Wikipedia)
Analysis of information sources in references of the Wikipedia article "艾尔建" in Chinese language version.
refsWebsite
Global rank
Chinese rank
1st place
1st place
433rd place
602nd place
5th place
12th place
bbc.co.uk
- Pfizer seals $160bn Allergan deal to create drugs giant. BBC News. November 23, 2015 [2022-02-18]. （原始内容存档于2020-11-27）.
fortune.com
- From Actavis to Allergan: One pharma company's wild dealmaking journey. Forbes Magazine. 30 July 2015 [2019-09-30]. （原始内容存档于2020-09-27）.
For a master class in mergers and acquisitions, one need only look at the company formerly known as Actavis. Now called Allergan, after its $70 billion acquisition of that maker of Botox last fall, the pharmaceutical firm has undertaken a dizzying series of deals in just the last few years, reinventing and renaming itself in a fashion that might make the artist formerly known as The Artist Formerly Known As Prince proud.
sec.gov
- Allergan plc 2018 Form 10-K Annual Report. U.S. Securities and Exchange Commission. [2019-09-30]. （原始内容存档于2019-09-30）.
web.archive.org
- Allergan plc 2018 Form 10-K Annual Report. U.S. Securities and Exchange Commission. [2019-09-30]. （原始内容存档于2019-09-30）.
- From Actavis to Allergan: One pharma company's wild dealmaking journey. Forbes Magazine. 30 July 2015 [2019-09-30]. （原始内容存档于2020-09-27）.
For a master class in mergers and acquisitions, one need only look at the company formerly known as Actavis. Now called Allergan, after its $70 billion acquisition of that maker of Botox last fall, the pharmaceutical firm has undertaken a dizzying series of deals in just the last few years, reinventing and renaming itself in a fashion that might make the artist formerly known as The Artist Formerly Known As Prince proud.
- Liz Hoffman. The Tax Inversion Wave Keeps Rolling. Wall Street Journal. 7 July 2015 [2019-09-30]. （原始内容存档于2019-04-17）.
Horizon and other inverted companies are using their new, lower tax rates to turbocharge corporate takeovers. Applying those rates, often in the midteens, to profits of companies in the U.S., with a federal corporate rate of 35%, can yield extra savings on top of those traditionally wrung from mergers. Moreover, unlike the U.S., Ireland and most other countries, only tax profits earned in-country, giving companies the freedom and incentive to shift income to still-lower-tax jurisdictions.
- Pfizer seals $160bn Allergan deal to create drugs giant. BBC News. November 23, 2015 [2022-02-18]. （原始内容存档于2020-11-27）.
- Rockoff, Jonathan. Pfizer Walks Away From Allergan Deal. The Wall Street Journal. April 6, 2016 [2022-02-18]. （原始内容
存档于2022-02-18）. - Hoffman, Richard Rubin and Liz. New Rules on Tax Inversions Threaten Pfizer-Allergan Deal. Wall Street Journal. 2016-04-05 [2020-04-08]. ISSN 0099-9660. （原始内容存档于2022-02-18） （美国英语）.
worldcat.org
- Hoffman, Richard Rubin and Liz. New Rules on Tax Inversions Threaten Pfizer-Allergan Deal. Wall Street Journal. 2016-04-05 [2020-04-08]. ISSN 0099-9660. （原始内容存档于2022-02-18） （美国英语）.
wsj.com
- Jonathan D. Rockoff; Nina Trentmann. New Tax Law Haunts Inversion Deals. The Wall Street Journal. 11 February 2018.
Similarly, Allergan, a drugmaker that moved its headquarters to Ireland after a 2013 acquisition but gets about 80% of revenue in the U.S., expects the loss of deductions on intercompany loans will largely be balanced out by lower taxes on its U.S. sales.
- Liz Hoffman. The Tax Inversion Wave Keeps Rolling. Wall Street Journal. 7 July 2015 [2019-09-30]. （原始内容存档于2019-04-17）.
Horizon and other inverted companies are using their new, lower tax rates to turbocharge corporate takeovers. Applying those rates, often in the midteens, to profits of companies in the U.S., with a federal corporate rate of 35%, can yield extra savings on top of those traditionally wrung from mergers. Moreover, unlike the U.S., Ireland and most other countries, only tax profits earned in-country, giving companies the freedom and incentive to shift income to still-lower-tax jurisdictions.
- Rockoff, Jonathan. Pfizer Walks Away From Allergan Deal. The Wall Street Journal. April 6, 2016 [2022-02-18]. （原始内容存档于2022-02-18）.
- Hoffman, Richard Rubin and Liz. New Rules on Tax Inversions Threaten Pfizer-Allergan Deal. Wall Street Journal. 2016-04-05 [2020-04-08]. ISSN 0099-9660. （原始内容存档于2022-02-18） （美国英语）.